Precigen (PGEN) Interest & Investment Income (2012 - 2026)
Precigen's (PGEN) quarterly Interest & Investment Income came in at $683000.0 in Q1 2026, down 25.6% year-on-year from $918000.0 in Q1 2025, and down 35.99% on a QoQ basis from $1.1 million in Q4 2025.
Precigen (PGEN) Interest & Investment Income (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Interest & Investment Income data on file, last reported at $683000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 25.6% year-over-year to $683000.0 in Q1 2026; TTM through Mar 2026 was $3.0 million, a 72.45% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, up 126.73% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $683000.0, down from $1.1 million in the prior quarter.
- Over the last five years, Interest & Investment Income for PGEN reached as high as $1.1 million in Q4 2025 and fell as low as $2000.0 in Q4 2022.
- Historically, Interest & Investment Income has averaged $511000.0 across 5 years, with a median of $608000.0 in 2024.
- Across the five-year window, Interest & Investment Income slumped 95.24% in 2022 and surged 45950.0% in 2023, its largest moves.
- Year by year, Interest & Investment Income stood at $2000.0 in 2022, then jumped by 45950.0% to $921000.0 in 2023, then sank by 77.42% to $208000.0 in 2024, then soared by 412.98% to $1.1 million in 2025, then tumbled by 35.99% to $683000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $683000.0 in Q1 2026, $1.1 million in Q4 2025, and $534000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Precigen | 1.95 Bn | 1.95 Bn | 20.69 Mn | 683,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 683,000.00 |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 534,000.00 |
| Jun 30, 2025 | 696,000.00 |
| Mar 31, 2025 | 918,000.00 |
| Dec 31, 2024 | 208,000.00 |
| Sep 30, 2024 | 283,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Mar 31, 2024 | 608,000.00 |
| Dec 31, 2023 | 921,000.00 |
| Sep 30, 2023 | 856,000.00 |
| Jun 30, 2023 | 828,000.00 |
| Mar 31, 2023 | 633,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 56,000.00 |
| Jun 30, 2022 | 37,000.00 |
| Mar 31, 2022 | 38,000.00 |
| Dec 31, 2021 | 42,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Jun 30, 2021 | 49,000.00 |